Biotech Updates

USDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the US

March 27, 2024

Yield10 Bioscience, Inc. announced that the U.S. Department of Agriculture Animal and Plant Health Inspection Service (USDA-APHIS)'s Biotechnology Regulatory Services (BRS) has determined that Yield10's Camelina sativa (Camelina) varieties developed using genetic engineering to produce omega-3 fatty acids are not subject to the regulations under 7 CFR part 340, and may be grown and bred in the United States.

The global markets for omega-3 fatty acids include aquafeed used for salmon and trout farming, pet feed, baby formula, and nutraceutical and pharmaceutical products. Most omega-3 fatty acids are produced from ocean-caught fish. Production constraints and supply volatility of traditional fish oil sources are creating gaps in supply and driving the growing demand for new sources of omega-3. Utilizing Camelina as a land-based production platform could help provide a new and reliable supply of omega-3 fatty acids.

In 2023, Yield10 submitted two Requests for Regulatory Status Review (RSR) to the BRS under the SECURE Rule. The RSR filed in July 2023 was for Camelina engineered to produce approximately 16-20% eicosapentaenoic acid (EPA). An RSR filed in December 2023 covers producing 10% EPA and 10% docosahexaenoic acid (DHA), closely resembling the omega-3 EPA/DHA fatty acid profile of northern hemisphere fish oil.

“This regulatory milestone represents a critical step for enabling the ramp-up of Camelina planting to commercial scale in the U.S for producing omega-3 oil for key markets including aquafeed and human nutrition,” said Kristi Snell, Ph.D., Chief Science Officer of Yield10 Bioscience. Snell added that in 2024, Yield10 will focus on executing a development program, building seed inventory in anticipation of commercial scale planting, and engaging with potential commercial partners for the future sale of omega-3 oil and meal in target markets.

For more details, read the news release from Yield10 Bioscience.

You might also like: